Advances in miniature CRISPR-Cas proteins and their applications in gene editing

被引:4
|
作者
Wu, Huimin [1 ,2 ]
Sun, Yixiang [2 ]
Wang, Yimai [1 ,2 ]
Luo, Liqiang [1 ]
Song, Yizhi [2 ,3 ]
机构
[1] Shanghai Univ, Coll Sci, Dept Chem, Shanghai, Peoples R China
[2] Chinese Acad Sci, Suzhou Inst Biomed Engn & Technol, Suzhou, Peoples R China
[3] Univ Sci & Technol China, Sch Biomed Engn, Div Life Sci & Med, Suzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Miniature CRISPR-Cas proteins; Cas12; Gene editing; STRUCTURAL BASIS; DNA; IDENTIFICATION; INTERFERENCE; REPEATS; SYSTEMS; PHI;
D O I
10.1007/s00203-024-03962-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The CRISPR-Cas system consists of Cas proteins and single-stranded RNAs that recruit Cas proteins and specifically target the nucleic acid. Some Cas proteins can accurately cleave the target nucleic acid under the guidance of the single-stranded RNAs. Due to its exceptionally high specificity, the CRISPR-Cas system is now widely used in various fields such as gene editing, transcription regulation, and molecular diagnosis. However, the huge size of the most frequently utilized Cas proteins (Cas9, Cas12a, and Cas13, which contain 950-1,400 amino acids) can limit their applicability, especially in eukaryotic gene editing, where larger Cas proteins are difficult to deliver into the target cells. Recently discovered miniature CRISPR-Cas proteins, consisting of only 400 to 800 amino acids, offer the possibility of overcoming this limitation. This article systematically reviews the latest research progress of several miniature CRISPR-Cas proteins (Cas12f, Cas12j, Cas12k, and Cas12m) and their practical applications in the field of gene editing.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing
    Frazer Sinclair
    Anjuman A. Begum
    Charles C. Dai
    Istvan Toth
    Peter M. Moyle
    Drug Delivery and Translational Research, 2023, 13 : 1500 - 1519
  • [22] Genome editing using CRISPR-Cas nucleases
    Joung, J. K.
    HUMAN GENE THERAPY, 2016, 27 (11) : A7 - A7
  • [23] Harnessing CRISPR-Cas for oomycete genome editing
    Vink, Jochem N. A.
    Hayhurst, Max
    Gerth, Monica L.
    TRENDS IN MICROBIOLOGY, 2023, 31 (09) : 947 - 958
  • [24] The CRISPR-Cas system: beyond genome editing
    Moineau, Sylvain
    Croteau, Felix R.
    Rousseau, Genevieve M.
    M S-MEDECINE SCIENCES, 2018, 34 (10): : 813 - 819
  • [25] Genome Editing in Bacteria: CRISPR-Cas and Beyond
    Arroyo-Olarte, Ruben D.
    Bravo Rodriguez, Ricardo
    Morales-Rios, Edgar
    MICROORGANISMS, 2021, 9 (04)
  • [26] Engineering miniature CRISPR-Cas Un1Cas12f1 for efficient base editing
    Hu, Yueer
    Han, Linxiao
    Mo, Qiqin
    Du, Zengming
    Jiang, Wei
    Wu, Xia
    Zheng, Jing
    Xiao, Xiao
    Sun, Yadong
    Ma, Hanhui
    MOLECULAR THERAPY NUCLEIC ACIDS, 2024, 35 (02):
  • [27] CRISPR/Cas genome editing in tomato improvement: Advances and applications
    Tiwari, Jagesh Kumar
    Singh, Anand Kumar
    Behera, Tusar Kanti
    FRONTIERS IN PLANT SCIENCE, 2023, 14
  • [28] Principles and medical applications of gene editing by CRISPR / Cas
    Sanchez Artigas, Rolando
    Diaz Armas, Maria Teresa
    Rodriguez Duque, Raisa
    Miguel Soca, Pedro Enrique
    MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS, 2021, 19 (06): : 1005 - 1014
  • [29] Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine
    Azeez, Sarkar Sardar
    Hamad, Rahin Shareef
    Hamad, Bahra Kakamin
    Shekha, Mudhir Sabir
    Bergsten, Peter
    FRONTIERS IN GENOME EDITING, 2024, 6
  • [30] CRISPR-Cas Technology as a Revolutionary Genome Editing tool: Mechanisms and Biomedical Applications
    Ebrahimi, Sahar
    Khosravi, Mohammad Ali
    Raz, Abbasali
    Karimipoor, Morteza
    Parvizi, Parviz
    IRANIAN BIOMEDICAL JOURNAL, 2023, 27 (05) : 219 - 246